Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

A comparison of internal target volume definition by limited four-dimensional computed tomography, the addition of patient-specific margins, or the addition of generic margins when planning radical radiotherapy for lymph node-positive non-small cell lung cancer.

Hughes S, McClelland J, Chandler A, Adams M, Boutland J, Withers D, Ahmad S, Blackall J, Tarte S, Hawkes D, Landau D.

Clin Oncol (R Coll Radiol). 2008 May;20(4):293-300. doi: 10.1016/j.clon.2007.12.004. Epub 2008 Jan 30.

PMID:
18234482
2.

Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer.

Shih HA, Jiang SB, Aljarrah KM, Doppke KP, Choi NC.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):613-22.

PMID:
15380599
3.

Comparison of IGRT registration strategies for optimal coverage of primary lung tumors and involved nodes based on multiple four-dimensional CT scans obtained throughout the radiotherapy course.

Mohammed N, Kestin L, Grills I, Shah C, Glide-Hurst C, Yan D, Ionascu D.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1541-8. doi: 10.1016/j.ijrobp.2011.04.025. Epub 2011 Jun 12.

PMID:
21664070
4.

An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients.

Bosmans G, Buijsen J, Dekker A, Velders M, Boersma L, De Ruysscher D, Minken A, Lambin P.

Radiother Oncol. 2006 Oct;81(1):73-80. Epub 2006 Sep 12.

PMID:
16971010
5.

Use of Maximum Intensity Projections (MIPs) for target outlining in 4DCT radiotherapy planning.

Muirhead R, McNee SG, Featherstone C, Moore K, Muscat S.

J Thorac Oncol. 2008 Dec;3(12):1433-8. doi: 10.1097/JTO.0b013e31818e5db7.

6.

Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer.

Underberg RW, Lagerwaard FJ, Cuijpers JP, Slotman BJ, van Sörnsen de Koste JR, Senan S.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1283-90.

PMID:
15519801
7.

Defining the margins in the radical radiotherapy of non-small cell lung cancer (NSCLC) with active breathing control (ABC) and the effect on physical lung parameters.

Panakis N, McNair HA, Christian JA, Mendes R, Symonds-Tayler JR, Knowles C, Evans PM, Bedford J, Brada M.

Radiother Oncol. 2008 Apr;87(1):65-73. doi: 10.1016/j.radonc.2007.12.012. Epub 2008 Feb 11.

PMID:
18267345
8.

Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.

Admiraal MA, Schuring D, Hurkmans CW.

Radiother Oncol. 2008 Jan;86(1):55-60. Epub 2007 Dec 20.

PMID:
18082905
9.

The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.

Shaverdian N, Tenn S, Veruttipong D, Wang J, Hegde J, Lee C, Cao M, Agazaryan N, Steinberg M, Kupelian P, Lee P.

Br J Radiol. 2016;89(1059):20150963. doi: 10.1259/bjr.20150963. Epub 2016 Jan 14.

10.

Evaluation of the influence of breathing on the movement and modeling of lung tumors.

Allen AM, Siracuse KM, Hayman JA, Balter JM.

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1251-7.

PMID:
15001270
11.

Differential motion between mediastinal lymph nodes and primary tumor in radically irradiated lung cancer patients.

Schaake EE, Rossi MM, Buikhuisen WA, Burgers JA, Smit AA, Belderbos JS, Sonke JJ.

Int J Radiat Oncol Biol Phys. 2014 Nov 15;90(4):959-66. doi: 10.1016/j.ijrobp.2014.07.038. Epub 2014 Oct 18.

PMID:
25585787
12.

Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients.

Knap MM, Hoffmann L, Nordsmark M, Vestergaard A.

Acta Oncol. 2010 Oct;49(7):1077-84. doi: 10.3109/0284186X.2010.498434.

PMID:
20831499
13.

Evaluation of target coverage and margins adequacy during CyberKnife Lung Optimized Treatment.

Ricotti R, Seregni M, Ciardo D, Vigorito S, Rondi E, Piperno G, Ferrari A, Zerella MA, Arculeo S, Francia CM, Sibio D, Cattani F, De Marinis F, Spaggiari L, Orecchia R, Riboldi M, Baroni G, Jereczek-Fossa BA.

Med Phys. 2018 Apr;45(4):1360-1368. doi: 10.1002/mp.12804. Epub 2018 Mar 12.

14.

Geometrical differences in gross target volumes between 3DCT and 4DCT imaging in radiotherapy for non-small-cell lung cancer.

Li F, Li J, Zhang Y, Xu M, Shang D, Fan T, Liu T, Shao Q.

J Radiat Res. 2013 Sep;54(5):950-6. doi: 10.1093/jrr/rrt017. Epub 2013 Apr 5.

15.

Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer.

Ge H, Cai J, Kelsey CR, Yin FF.

Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):438-43. doi: 10.1016/j.ijrobp.2012.04.032. Epub 2012 Jun 9.

PMID:
22687196
16.

[Target volume margins for lung cancer: internal target volume/clinical target volume].

Jouin A, Pourel N.

Cancer Radiother. 2013 Oct;17(5-6):428-33. doi: 10.1016/j.canrad.2013.05.008. Epub 2013 Aug 27. Review. French.

PMID:
23988437
18.

Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.

Underberg RW, Lagerwaard FJ, Slotman BJ, Cuijpers JP, Senan S.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):554-60.

PMID:
15890600
19.

Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning.

Sher DJ, Wolfgang JA, Niemierko A, Choi NC.

Int J Radiat Oncol Biol Phys. 2007 Dec 1;69(5):1402-8. Epub 2007 Oct 24.

PMID:
17920783
20.

Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool.

van Dam IE, van Sörnsen de Koste JR, Hanna GG, Muirhead R, Slotman BJ, Senan S.

Radiother Oncol. 2010 Jul;96(1):67-72. doi: 10.1016/j.radonc.2010.05.003.

PMID:
20570381

Supplemental Content

Support Center